4//SEC Filing
Verwijs Marinus 4
Accession 0001415889-24-012235
CIK 0001798749other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 6:00 PM ET
Size
5.5 KB
Accession
0001415889-24-012235
Insider Transaction Report
Form 4
Verwijs Marinus
Senior Vice President, CMC
Transactions
- Sale
Common Stock
2024-05-02$21.02/sh−1,981$41,631→ 0 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to E*TRADE Securities LLC's Quicksale Trading Plan elected by the reporting person on July 11, 2022.
- [F2]Includes 1,981 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2024 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d).
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.972 to $21.12, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
Aerovate Therapeutics, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001916553
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 6:00 PM ET
- Size
- 5.5 KB